CHU Besançon
Besançon, 25000, France
NCT Number: NCT02857413
The aim of this study is the evaluation of the frequency of xerostomia and their management after radiotherapy in head and neck cancer.
The quality of life of these patients is also analysed with European Organization for Research and Treatment of Cancer Quality of life Questionnaire H&N35 (EORTC QLQ H&N35).
Looking for future studies?
Notify MeAll sexes
Observational
Besançon, 25000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at enrollment
patients describe the severity of their xerostomia and their management in a standardized questionnaire
Time frame: at enrollment
patients describe their quality of life in a standardized questionnaire
Centre Hospitalier Universitaire de Besancon
Other
Assessment of Frequency of Xerostomia and Their Care Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy
Acronym: XEROSTOMIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05614843
Head and Neck Cancer, Head and Neck Neoplasms
Granada, Spain
View Trial DetailsNCT02941276
Head and Neck Neoplasms, Mouth Diseases
View Trial DetailsNCT00138827
Digestive System Diseases, Gastroenteritis
Sydney, New South Wales, Australia
View Trial DetailsNCT07711626
Cancer-related Fatigue, Dyssomnias
Hualien City, Taiwan
View Trial Details